Clinical Trials Browser

Completed × Interventional × Dacarbazine × Clear all

NCT00600496 2026-05-27

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms

NCT01476410 2026-05-22

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Phase 2 Completed

49 enrolled 25 charts

Hodgkin Disease

NCT03070392 2026-03-17

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Phase 2 Completed

378 enrolled 15 charts 1 FDA

Uveal Melanoma, Melanoma

NCT01712490 2026-02-27

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Phase 3 Completed

1,334 enrolled 23 charts

Hodgkin Disease, Lymphoma

NCT04225390 2026-02-10

PROMIT

Phase 2 Completed

Immunotherapy

NCT03159897 2025-08-08

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Phase 3 Completed

Hodgkin Disease

NCT00049595 2025-08-05

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

Phase 3 Completed

Hodgkin Disease, Lymphoma

NCT03331341 2025-08-05

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

Phase 1/2 Completed

50 enrolled 10 charts

Hodgkin Disease

NCT03023124 2024-12-09

STRADA

Phase 2 Completed

Solitary Fibrous Tumors

NCT03430297 2024-09-19

JS001

Phase 3 Completed

Melanoma

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT01716806 2024-06-11

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

Phase 2 Completed

131 enrolled 28 charts

Hematologic Diseases, Hodgkin Disease, Lymphoma, Lymphoma, T-Cell, Peripheral

NCT00678327 2024-05-08

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Phase 3 Completed

Hodgkin Disease, Lymphoma

NCT03761095 2024-03-15

A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Phase 1 Completed

Leiomyosarcoma

NCT02181738 2023-11-28

CheckMate 205

Phase 2 Completed

294 enrolled 32 charts

Hodgkin Disease

NCT01152788 2023-08-22

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

Phase 2 Completed

64 enrolled 10 charts

Melanoma

NCT00003389 2023-06-29

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Phase 3 Completed

854 enrolled 9 charts

Hodgkin Disease, Lymphoma

NCT00003027 2023-06-22

Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

Phase 3 Completed

Melanoma

NCT05898451 2023-06-12

R-2

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT01359956 2023-04-11

SICOG 0109

Phase 3 Completed

269 enrolled 12 charts

Melanoma

NCT02292979 2022-08-19

BREACH

Phase 2 Completed

Hodgkin Disease

NCT00822120 2022-08-18

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

Phase 2 Completed

371 enrolled 14 charts

Hodgkin Disease, Lymphoma, HIV Infections

NCT01835145 2022-08-04

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Phase 2 Completed

47 enrolled 12 charts

Uveal Melanoma

NCT01721772 2022-07-12

CheckMate 066

Phase 3 Completed

418 enrolled 16 charts

Melanoma

NCT00130442 2022-06-23

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

Phase 2 Completed

134 enrolled 16 charts

Melanoma

NCT01721746 2022-04-19

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Phase 3 Completed

405 enrolled 16 charts

Melanoma

NCT00000626 2021-10-27

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Phase 2 Completed

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Hodgkin Disease, HIV Infections

NCT01132807 2021-06-14

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Phase 2 Completed

164 enrolled 7 charts

Hodgkin Disease, Lymphoma

NCT01763164 2021-03-22

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

Phase 3 Completed

402 enrolled 21 charts

Melanoma, Neoplasm Metastasis, Skin Diseases, Skin Neoplasms

NCT02505269 2020-08-24

Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma

Phase 2 Completed

34 enrolled 7 charts

Hodgkin Disease

NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Phase 1 Completed

CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

NCT02545075 2020-05-19

A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine

Phase 3 Completed

182 enrolled 20 charts

Melanoma

NCT01704287 2020-05-18

KEYNOTE 002

Phase 2 Completed

540 enrolled 20 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT00002561 2020-04-14

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

Phase 3 Completed

Hodgkin Disease

NCT01356680 2020-04-06

HD17 for Intermediate Stage Hodgkin Lymphoma

Phase 3 Completed

Hodgkin Disease

NCT00416832 2020-03-26

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma

NCT00433459 2020-03-26

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Phase 3 Completed

Hodgkin Disease, Lymphoma

NCT00864253 2019-10-30

A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

Phase 3 Completed

529 enrolled 22 charts

Melanoma

NCT01551459 2019-10-29

SUAVE

Phase 2 Completed

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT01100528 2019-02-26

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Phase 2 Completed

38 enrolled 10 charts

Uveal Melanoma

NCT00038558 2018-10-31

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Phase 3 Completed

Hodgkin Disease

NCT01569204 2018-10-29

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

Phase 2 Completed

Hodgkin Disease

NCT00369681 2018-08-27

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Phase 2 Completed

51 enrolled 8 charts

Hodgkin Disease, Lymphoma

NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Phase 3 Completed

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT01056679 2018-03-22

AVD-Rev

Phase 1 Completed

Hodgkin Disease

NCT01534078 2018-02-20

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma

Phase 2 Completed

34 enrolled 15 charts

Hodgkin Disease

NCT01693068 2018-01-05

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Phase 2 Completed

194 enrolled 15 charts

Melanoma

NCT01227889 2017-10-04

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

Phase 3 Completed

251 enrolled 21 charts

Melanoma, Neoplasms

NCT00715793 2017-10-03

UPCI-07-008

Phase 1/2 Completed

39 enrolled 12 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT01143402 2017-07-26

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Phase 2 Completed

120 enrolled 8 charts

Uveal Melanoma